Cargando…

Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Markers for Predicting the Severity in COVID-19 Patients: A Prospective Observational Study

Background: Coronavirus disease-2019 (COVID-19) pandemic has shown unpredictable course in individual patients. Few patients develop severe disease with progression after admission to a healthcare facility. Multiple parameters have been investigated to identify a marker to predict disease progressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Yudhyavir, Singh, Abhishek, Rudravaram, Swetha, Soni, Kapil D, Aggarwal, Richa, Patel, Nishant, Wig, Naveet, Trikha, Anjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559739/
https://www.ncbi.nlm.nih.gov/pubmed/34733022
http://dx.doi.org/10.5005/jp-journals-10071-23906
_version_ 1784592820068155392
author Singh, Yudhyavir
Singh, Abhishek
Rudravaram, Swetha
Soni, Kapil D
Aggarwal, Richa
Patel, Nishant
Wig, Naveet
Trikha, Anjan
author_facet Singh, Yudhyavir
Singh, Abhishek
Rudravaram, Swetha
Soni, Kapil D
Aggarwal, Richa
Patel, Nishant
Wig, Naveet
Trikha, Anjan
author_sort Singh, Yudhyavir
collection PubMed
description Background: Coronavirus disease-2019 (COVID-19) pandemic has shown unpredictable course in individual patients. Few patients develop severe disease with progression after admission to a healthcare facility. Multiple parameters have been investigated to identify a marker to predict disease progression. Neutrophil-to-lymphocyte ratio (NLR) or platelet-to-lymphocyte (PLR) ratio has shown some promise. The current investigation explores the role of NLR and PLR to predict the disease progression. Materials and methods: After obtaining ethics committee approval, 608 patients were screened for inclusion in the prospective observational study, and 201 patients were included in the final analysis. The NLR and PLR were derived from routinely obtained complete blood count analysis. The patients were followed to determine the development of severity of the disease during the course. The NLR and PLR were analyzed in both univariate and multivariable models to assess the association and prediction. Results: In nonsevere (NS) group, the mean age of patients was 50.9 ± 16.3 years, and 66 (61.2%) were male, while in severe group (S), the mean age of patients was 53.7 ± 16.4 years, and 65 (69.89%) were male. NLR at day 1 and day 3 was significantly lower in survivors as compared to nonsurvivors, while the relation of PLR in both the groups was not statistically significant. The NLR is better in predicting the severity of disease as well as mortality than PLR. Conclusion: The NLR calculated at the time of admission has high predictive value for disease deterioration and adverse clinical outcome. How to cite this article: Singh Y, Singh A, Rudravaram S, Soni KD, Aggarwal R, Patel N, et al. Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Markers for Predicting the Severity in COVID-19 Patients: A Prospective Observational Study. Indian J Crit Care Med 2021;25(8):847–852.
format Online
Article
Text
id pubmed-8559739
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-85597392021-11-02 Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Markers for Predicting the Severity in COVID-19 Patients: A Prospective Observational Study Singh, Yudhyavir Singh, Abhishek Rudravaram, Swetha Soni, Kapil D Aggarwal, Richa Patel, Nishant Wig, Naveet Trikha, Anjan Indian J Crit Care Med Original Article Background: Coronavirus disease-2019 (COVID-19) pandemic has shown unpredictable course in individual patients. Few patients develop severe disease with progression after admission to a healthcare facility. Multiple parameters have been investigated to identify a marker to predict disease progression. Neutrophil-to-lymphocyte ratio (NLR) or platelet-to-lymphocyte (PLR) ratio has shown some promise. The current investigation explores the role of NLR and PLR to predict the disease progression. Materials and methods: After obtaining ethics committee approval, 608 patients were screened for inclusion in the prospective observational study, and 201 patients were included in the final analysis. The NLR and PLR were derived from routinely obtained complete blood count analysis. The patients were followed to determine the development of severity of the disease during the course. The NLR and PLR were analyzed in both univariate and multivariable models to assess the association and prediction. Results: In nonsevere (NS) group, the mean age of patients was 50.9 ± 16.3 years, and 66 (61.2%) were male, while in severe group (S), the mean age of patients was 53.7 ± 16.4 years, and 65 (69.89%) were male. NLR at day 1 and day 3 was significantly lower in survivors as compared to nonsurvivors, while the relation of PLR in both the groups was not statistically significant. The NLR is better in predicting the severity of disease as well as mortality than PLR. Conclusion: The NLR calculated at the time of admission has high predictive value for disease deterioration and adverse clinical outcome. How to cite this article: Singh Y, Singh A, Rudravaram S, Soni KD, Aggarwal R, Patel N, et al. Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Markers for Predicting the Severity in COVID-19 Patients: A Prospective Observational Study. Indian J Crit Care Med 2021;25(8):847–852. Jaypee Brothers Medical Publishers 2021-08 /pmc/articles/PMC8559739/ /pubmed/34733022 http://dx.doi.org/10.5005/jp-journals-10071-23906 Text en Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd. https://creativecommons.org/licenses/by-nc/4.0/© Jaypee Brothers Medical Publishers. 2021 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Article
Singh, Yudhyavir
Singh, Abhishek
Rudravaram, Swetha
Soni, Kapil D
Aggarwal, Richa
Patel, Nishant
Wig, Naveet
Trikha, Anjan
Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Markers for Predicting the Severity in COVID-19 Patients: A Prospective Observational Study
title Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Markers for Predicting the Severity in COVID-19 Patients: A Prospective Observational Study
title_full Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Markers for Predicting the Severity in COVID-19 Patients: A Prospective Observational Study
title_fullStr Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Markers for Predicting the Severity in COVID-19 Patients: A Prospective Observational Study
title_full_unstemmed Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Markers for Predicting the Severity in COVID-19 Patients: A Prospective Observational Study
title_short Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Markers for Predicting the Severity in COVID-19 Patients: A Prospective Observational Study
title_sort neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as markers for predicting the severity in covid-19 patients: a prospective observational study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559739/
https://www.ncbi.nlm.nih.gov/pubmed/34733022
http://dx.doi.org/10.5005/jp-journals-10071-23906
work_keys_str_mv AT singhyudhyavir neutrophiltolymphocyteratioandplatelettolymphocyteratioasmarkersforpredictingtheseverityincovid19patientsaprospectiveobservationalstudy
AT singhabhishek neutrophiltolymphocyteratioandplatelettolymphocyteratioasmarkersforpredictingtheseverityincovid19patientsaprospectiveobservationalstudy
AT rudravaramswetha neutrophiltolymphocyteratioandplatelettolymphocyteratioasmarkersforpredictingtheseverityincovid19patientsaprospectiveobservationalstudy
AT sonikapild neutrophiltolymphocyteratioandplatelettolymphocyteratioasmarkersforpredictingtheseverityincovid19patientsaprospectiveobservationalstudy
AT aggarwalricha neutrophiltolymphocyteratioandplatelettolymphocyteratioasmarkersforpredictingtheseverityincovid19patientsaprospectiveobservationalstudy
AT patelnishant neutrophiltolymphocyteratioandplatelettolymphocyteratioasmarkersforpredictingtheseverityincovid19patientsaprospectiveobservationalstudy
AT wignaveet neutrophiltolymphocyteratioandplatelettolymphocyteratioasmarkersforpredictingtheseverityincovid19patientsaprospectiveobservationalstudy
AT trikhaanjan neutrophiltolymphocyteratioandplatelettolymphocyteratioasmarkersforpredictingtheseverityincovid19patientsaprospectiveobservationalstudy